Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 796 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 176-200 of 796 matching filings.

Per page
25
Current page
8
SC 13G/A File 005-89140

SCHEDULE 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jan 2024
Reporting date
18 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jan 2024
Reporting date
18 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jan 2024
Reporting date
18 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jan 2024
Reporting date
18 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jan 2024
Reporting date
18 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jan 2024
Reporting date
18 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Dec 2023
Reporting date
20 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Dec 2023
Reporting date
20 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Dec 2023
Reporting date
20 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Dec 2023
Reporting date
20 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Dec 2023
Reporting date
20 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2023
Reporting date
17 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2023
Reporting date
17 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2023
Reporting date
17 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2023
Reporting date
17 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2023
Reporting date
17 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Sep 2023
Reporting date
20 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Sep 2023
Reporting date
20 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Sep 2023
Reporting date
20 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Sep 2023
Reporting date
20 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-274010

424B3

Filing date
28 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-274010

EFFECT filing

Filing date
25 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .